Results 151 to 160 of about 76,767 (289)

Hyperthyroidism in the elderly

, 2005
Hyperthyroidism in elderly patients is not to be under- evaluated, since it is characterized in such age range by particular clinical and prognostic features.
CATANI M, MANILI G, PIETROLETTI R, SIMI M, LEARDI S, CAPITANO S., BASCHIERI I, RONGA, Giuseppe   +7 more
core   +1 more source

Pharmacological Management of Thyroid Diseases

The thyroid gland produces T3 and T4, which regulate metabolism, and imbalances in these hormones can lead to serious conditions. Hyperthyroidism is commonly treated with antithyroid drugs like methimazole or PTU, along with beta-blockers for symptom ...
Yun, Minsang
core  

Systemic Disease Associations of Oral Lichenoid Disease: A Retrospective Case–Control Study

Oral Diseases, EarlyView.
ABSTRACT Objective To analyze the association between oral lichen planus (OLP), oral lichenoid lesions (OLL), and other comorbidities. Material and Methods A case–control study of 205 OLP, 96 OLL patients, and 301 age‐ and sex‐matched controls from Kuopio University Hospital was performed.
Mari Vehviläinen, Tuomas Selander, Tuula Salo, Maria Siponen   +3 more
wiley   +1 more source

Superior sagittal sinus thrombosis secondary to hyperthyroidism

, 2000
Superior sagittal sinus thrombosis (SSST) is associated with a variety of hypercoaguable states. Although coagulation disturbances are reported in hyperthyroidism, a direct link between hyperthyroidism and cerebral venous thrombosis is not established ...
Bakshi, Rohit, Dubey, Neeraj, Dai, Alper, Giglio, Pierre, Wasay, Mohammad   +4 more
core  

PFA Under Deep Sedation and Non‐Invasive Monitoring in Atrial Fibrillation Patients With Obstructive Sleep Apnea

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Clinical data about pulsed field ablation (PFA) under deep sedation among patients with obstructive sleep apnea (OSA) are limited, while the optimal periprocedural monitoring is not established. We report our experience in PFA among patients with atrial fibrillation (AF) and OSA, using a continuous non‐invasive respiratory and ...
Dionyssios Leftheriotis, Konstantinos A. Papathanasiou, Efstratios Karamanolis, Areti Vlachodiamanti, Evangelia Stamatopoulou, Maria Polikandrioti, Panagiota Flevari   +6 more
wiley   +1 more source

Thyroid dysfunction and cardiovascular disease. [PDF]

Eur Heart J
Alwan H, Hysaj O, Gencer B, Duntas L, Rodondi N.   +4 more
europepmc   +1 more source

Representation, medical examination, and the effectiveness of underwriting: Evidence from a life and health insurance company

Risk Management and Insurance Review, EarlyView.
Abstract This study examines whether underwriting methods—representation, medical examination, extra premiums, and coverage—effectively mitigate adverse selection using data from an insurance company. Regarding representation, we focus on statements disclosing pre‐existing medical conditions.
Chia‐Ling Ho, Gene Lai, Chen‐Hsu Liao, Zifen Zeng   +3 more
wiley   +1 more source

Elucidating the cellular determinants of the end‐systolic pressure‐volume relationship of the heart via computational modelling

The Journal of Physiology, EarlyView.
Abstract figure legend Using a multiscale computational model of left ventricular electromechanics, we investigated how sarcomere dynamics influence the end‐systolic pressure‐volume (ESPV) relationship in ejecting beats compared to isovolumetric beats.
Francesco Regazzoni, Corrado Poggesi, Cecilia Ferrantini   +2 more
wiley   +1 more source

Organic Psychosis Secondary to Untreated Graves' Disease: A Case Report. [PDF]

Cureus
Ahmad KA, Che Man M.
europepmc   +1 more source

14‐3‐3 proteins: Regulators of cardiac excitation–contraction coupling and stress responses

The Journal of Physiology, EarlyView.
Abstract figure legend 14‐3‐3 protein interactions in cardiac regulation. Schematic representation of 14‐3‐3 binding partners in excitation–contraction coupling, transcriptional regulation/development and stress response pathways. Asterisks indicate targets where the exact 14‐3‐3 binding site is unknown.
Heather C. Spooner, Rose E. Dixon
wiley   +1 more source